Molecular mechanisms for drug interactions with hERG that cause long QT syndrome.
about
Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperatureIntegrated risk assessment and predictive value to humans of non-clinical repolarization assays.New Trends in Cancer Therapy: Targeting Ion Channels and Transporters.Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking.Can non-clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium.Probing the molecular basis of hERG drug block with unnatural amino acids.
P2860
Molecular mechanisms for drug interactions with hERG that cause long QT syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Molecular mechanisms for drug interactions with hERG that cause long QT syndrome.
@ast
Molecular mechanisms for drug interactions with hERG that cause long QT syndrome.
@en
type
label
Molecular mechanisms for drug interactions with hERG that cause long QT syndrome.
@ast
Molecular mechanisms for drug interactions with hERG that cause long QT syndrome.
@en
prefLabel
Molecular mechanisms for drug interactions with hERG that cause long QT syndrome.
@ast
Molecular mechanisms for drug interactions with hERG that cause long QT syndrome.
@en
P2093
P2860
P50
P356
P1476
Molecular mechanisms for drug interactions with hERG that cause long QT syndrome
@en
P2093
John S Mitcheson
Michael J Sutcliffe
Phillip J Stansfeld
P2860
P356
10.1517/17425255.2.1.81
P407
P577
2006-02-01T00:00:00Z